24/7 Patient Assistance: 760-405-8205

Ewa Mrozek , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Ewa Mrozek is a medical oncologist from Lima, Ohio and she works at several hospitals in the area, such as James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. She did her Medical Schooling from Gdański Uniwersytet Medyczny and Residency in Internal Medicine from New York Methodist Hospital. The doctor is certified in Medical Oncology from American Board of Internal Medicine and has an experience of more than 20 years.

  • Education & Training


    Gdański Uniwersytet Medyczny

    Medical School


    New York Methodist Hospital



    Ohio State University Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    James Cancer Hospital and Solove Research Institute

    Languages: English/Spanish

    (614) 293-5066

    460 W 10th Ave

    Columbus, Ohio 43210

    Read More
  • Publications & Memberships

    Dr. Ewa Mrozek has contributed to 3 publications.

    Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer.

    Vargo, C. A.,Berger, M. J.,Phillips, G.,Mrozek, E.; Support Care Cancer. 2016 Feb 06.

    See more >>

    Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.

    Hicks, M.,Macrae, E. R.,Abdel-Rasoul, M.,Layman, R.,Friedman, S.,Querry, J.,Lustberg, M.,Ramaswamy, B.,Mrozek, E.,Shapiro, C.,Wesolowski, R.; Oncologist. 2015 Mar 04.

    See more >>

    Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

    Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Sum...; Breast Cancer Res.. 2014-03-06.

    See more >>